APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antacid

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

Selected research

Market Structure

Global Antacid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025195 pages

Choose your research edition.

Industry ResearchAntacid Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Antacid Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antacid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antacid Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Antacid Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.

Read the full market overview

In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.

This report provides an overview of the global Antacid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antacid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antacid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antacid market size, projected growth trends, production technologies, key applications, and end-use industries.

Antacid Segment by Company

AstraZeneca

Takeda Pharmaceutical

Pfizer

Reckitt Benckiser

Bayer

Procter＆Gamble

GlaxoSmithKline

Johnson＆Johnson

CONBA

Xiuzheng Pharma

Sanofi

Bausch Health

CR SANJIU

Reddy's Laboratories

Antacid Segment by Type

Proton Pump Inhibitor

H2 Antagonist

Acid Neutralizers

Antacid Segment by Application

OTC Drug

Rx Drug

Antacid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antacid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antacid market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antacid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antacid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antacid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antacid Industry Trends Table 2. Antacid Industry Drivers Table 3. Antacid Industry Opportunities and Challenges Table 4. Antacid Industry Restraints Table 5. Global Antacid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antacid Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antacid Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Antacid Sales Market Share by Manufacturers Table 9. Global Antacid Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Antacid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antacid Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antacid Manufacturers, Product Type & Application Table 13. Global Antacid Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antacid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Proton Pump Inhibitor Table 17. Major Manufacturers of H2 Antagonist Table 18. Major Manufacturers of Acid Neutralizers Table 19. Global Antacid Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 20. Global Antacid Sales by Type (2021-2026) & (M Units) Table 21. Global Antacid Sales by Type (2027-2032) & (M Units) Table 22. Global Antacid Sales Market Share by Type (2021-2026) Table 23. Global Antacid Sales Market Share by Type (2027-2032) Table 24. Global Antacid Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 25. Global Antacid Revenue by Type (2021-2026) & (M Units) Table 26. Global Antacid Revenue by Type (2027-2032) & (M Units) Table 27. Global Antacid Revenue Market Share by Type (2021-2026) Table 28. Global Antacid Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of OTC Drug Table 30. Major Manufacturers of Rx Drug Table 31. Global Antacid Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 32. Global Antacid Sales by Application (2021-2026) & (M Units) Table 33. Global Antacid Sales by Application (2027-2032) & (M Units) Table 34. Global Antacid Sales Market Share by Application (2021-2026) Table 35. Global Antacid Sales Market Share by Application (2027-2032) Table 36. Global Antacid Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 37. Global Antacid Revenue by Application (2021-2026) & (M Units) Table 38. Global Antacid Revenue by Application (2027-2032) & (M Units) Table 39. Global Antacid Revenue Market Share by Application (2021-2026) Table 40. Global Antacid Revenue Market Share by Application (2027-2032) Table 41. Global Antacid Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 42. Global Antacid Sales by Region (2021-2026) & (M Units) Table 43. Global Antacid Sales Market Share by Region (2021-2026) Table 44. Global Antacid Sales Forecasted by Region (2027-2032) & (M Units) Table 45. Global Antacid Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Antacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 47. North America Antacid Sales by Country (2021-2026) & (M Units) Table 48. North America Antacid Sales by Country (2027-2032) & (M Units) Table 49. Europe Antacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. Europe Antacid Sales by Country (2021-2026) & (M Units) Table 51. Europe Antacid Sales by Country (2027-2032) & (M Units) Table 52. Asia Pacific Antacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Asia Pacific Antacid Sales by Country (2021-2026) & (M Units) Table 54. Asia Pacific Antacid Sales by Country (2027-2032) & (M Units) Table 55. South America, Middle East and Africa Antacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. South America, Middle East and Africa Antacid Sales by Country (2021-2026) & (M Units) Table 57. South America, Middle East and Africa Antacid Sales by Country (2027-2032) & (M Units) Table 58. Global Antacid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Antacid Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Antacid Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Antacid Revenue Market Share by Region (2021-2026) Table 62. Global Antacid Revenue Market Share by Region (2027-2032) Table 63. AstraZeneca Company Information Table 64. AstraZeneca Business Overview Table 65. AstraZeneca Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. AstraZeneca Antacid Product Portfolio Table 67. AstraZeneca Recent Development Table 68. Takeda Pharmaceutical Company Information Table 69. Takeda Pharmaceutical Business Overview Table 70. Takeda Pharmaceutical Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Takeda Pharmaceutical Antacid Product Portfolio Table 72. Takeda Pharmaceutical Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pfizer Antacid Product Portfolio Table 77. Pfizer Recent Development Table 78. Reckitt Benckiser Company Information Table 79. Reckitt Benckiser Business Overview Table 80. Reckitt Benckiser Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Reckitt Benckiser Antacid Product Portfolio Table 82. Reckitt Benckiser Recent Development Table 83. Bayer Company Information Table 84. Bayer Business Overview Table 85. Bayer Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Bayer Antacid Product Portfolio Table 87. Bayer Recent Development Table 88. Procter＆Gamble Company Information Table 89. Procter＆Gamble Business Overview Table 90. Procter＆Gamble Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Procter＆Gamble Antacid Product Portfolio Table 92. Procter＆Gamble Recent Development Table 93. GlaxoSmithKline Company Information Table 94. GlaxoSmithKline Business Overview Table 95. GlaxoSmithKline Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. GlaxoSmithKline Antacid Product Portfolio Table 97. GlaxoSmithKline Recent Development Table 98. Johnson＆Johnson Company Information Table 99. Johnson＆Johnson Business Overview Table 100. Johnson＆Johnson Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Johnson＆Johnson Antacid Product Portfolio Table 102. Johnson＆Johnson Recent Development Table 103. CONBA Company Information Table 104. CONBA Business Overview Table 105. CONBA Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. CONBA Antacid Product Portfolio Table 107. CONBA Recent Development Table 108. Xiuzheng Pharma Company Information Table 109. Xiuzheng Pharma Business Overview Table 110. Xiuzheng Pharma Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Xiuzheng Pharma Antacid Product Portfolio Table 112. Xiuzheng Pharma Recent Development Table 113. Sanofi Company Information Table 114. Sanofi Business Overview Table 115. Sanofi Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sanofi Antacid Product Portfolio Table 117. Sanofi Recent Development Table 118. Bausch Health Company Information Table 119. Bausch Health Business Overview Table 120. Bausch Health Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Bausch Health Antacid Product Portfolio Table 122. Bausch Health Recent Development Table 123. CR SANJIU Company Information Table 124. CR SANJIU Business Overview Table 125. CR SANJIU Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. CR SANJIU Antacid Product Portfolio Table 127. CR SANJIU Recent Development Table 128. Reddy's Laboratories Company Information Table 129. Reddy's Laboratories Business Overview Table 130. Reddy's Laboratories Antacid Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Reddy's Laboratories Antacid Product Portfolio Table 132. Reddy's Laboratories Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Antacid Distributors List Table 136. Antacid Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Antacid Product Image Figure 2. Global Antacid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antacid Market Size (2021-2032) & (US$ Million) Figure 4. Global Antacid Sales (2021-2032) & (M Units) Figure 5. Global Antacid Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antacid Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Proton Pump Inhibitor Image Figure 9. H2 Antagonist Image Figure 10. Acid Neutralizers Image Figure 11. Global Antacid Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 12. Global Antacid Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Antacid Sales Market Share by Type (2021-2032) Figure 14. Global Antacid Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 15. Global Antacid Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Antacid Revenue Market Share by Type (2021-2032) Figure 17. OTC Drug Image Figure 18. Rx Drug Image Figure 19. Global Antacid Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 20. Global Antacid Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Antacid Sales Market Share by Application (2021-2032) Figure 22. Global Antacid Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Antacid Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Antacid Revenue Market Share by Application (2021-2032) Figure 25. North America Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 26. North America Antacid Sales Market Share by Country (2021-2032) Figure 27. U.S. Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 28. Canada Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 29. Mexico Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 30. Europe Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Europe Antacid Sales Market Share by Country (2021-2032) Figure 32. Germany Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 33. France Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 34. U.K. Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Italy Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Netherlands Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Asia Pacific Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Asia Pacific Antacid Sales Market Share by Country (2021-2032) Figure 39. China Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Japan Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 41. South Korea Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Southeast Asia Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 43. India Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Australia Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 45. South America, Middle East and Africa Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 46. South America, Middle East and Africa Antacid Sales Market Share by Country (2021-2032) Figure 47. Brazil Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South Africa Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Saudi Arabia Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Turkey Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Argentina Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 52. UAE Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Egypt Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Chile Antacid Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Global Antacid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Antacid Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Antacid Revenue (2021-2032) & (US$ Million) Figure 58. North America Antacid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Antacid Revenue (2021-2032) & (US$ Million) Figure 60. Europe Antacid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antacid Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Antacid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Antacid Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Antacid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Antacid Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Antacid Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Proton Pump Inhibitor
  • H2 Antagonist
  • Acid Neutralizers
Applications
  • OTC Drug
  • Rx Drug
Companies covered
  • AstraZeneca
  • Takeda Pharmaceutical
  • Pfizer
  • Reckitt Benckiser
  • Bayer
  • Procter＆Gamble
  • GlaxoSmithKline
  • Johnson＆Johnson
  • CONBA
  • Xiuzheng Pharma
  • Sanofi
  • Bausch Health
  • CR SANJIU
  • Reddy's Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antacid Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antacid Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antacid Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antacid Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antacid Market Dynamics
  1. 2.1 Antacid Industry Trends
  2. 2.2 Antacid Industry Drivers
  3. 2.3 Antacid Industry Opportunities and Challenges
  4. 2.4 Antacid Industry Restraints
3 Antacid Market by Manufacturers
  1. 3.1 Global Antacid Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antacid Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antacid Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antacid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antacid Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antacid Manufacturers, Product Type & Application
  7. 3.7 Global Antacid Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antacid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antacid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antacid Tier 1, Tier 2, and Tier 3
4 Antacid Market by Type
  1. 4.1 Antacid Type Introduction
  2. 4.1.1 Proton Pump Inhibitor
  3. 4.1.2 H2 Antagonist
  4. 4.1.3 Acid Neutralizers
  5. 4.2 Global Antacid Sales by Type
  6. 4.2.1 Global Antacid Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antacid Sales by Type (2021-2032)
  8. 4.2.3 Global Antacid Sales Market Share by Type (2021-2032)
  9. 4.3 Global Antacid Revenue by Type
  10. 4.3.1 Global Antacid Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Antacid Revenue by Type (2021-2032)
  12. 4.3.3 Global Antacid Revenue Market Share by Type (2021-2032)
5 Antacid Market by Application
  1. 5.1 Antacid Application Introduction
  2. 5.1.1 OTC Drug
  3. 5.1.2 Rx Drug
  4. 5.2 Global Antacid Sales by Application
  5. 5.2.1 Global Antacid Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antacid Sales by Application (2021-2032)
  7. 5.2.3 Global Antacid Sales Market Share by Application (2021-2032)
  8. 5.3 Global Antacid Revenue by Application
  9. 5.3.1 Global Antacid Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Antacid Revenue by Application (2021-2032)
  11. 5.3.3 Global Antacid Revenue Market Share by Application (2021-2032)
6 Global Antacid Sales by Region
  1. 6.1 Global Antacid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antacid Sales by Region (2021-2032)
  3. 6.2.1 Global Antacid Sales by Region (2021-2026)
  4. 6.2.2 Global Antacid Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antacid Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antacid Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antacid Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antacid Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antacid Revenue by Region
  1. 7.1 Global Antacid Revenue by Region
  2. 7.1.1 Global Antacid Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antacid Revenue by Region (2021-2026)
  4. 7.1.3 Global Antacid Revenue by Region (2027-2032)
  5. 7.1.4 Global Antacid Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antacid Revenue (2021-2032)
  8. 7.2.2 North America Antacid Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antacid Revenue (2021-2032)
  11. 7.3.2 Europe Antacid Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antacid Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antacid Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antacid Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antacid Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Antacid Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 Takeda Pharmaceutical
  8. 8.2.1 Takeda Pharmaceutical Company Information
  9. 8.2.2 Takeda Pharmaceutical Business Overview
  10. 8.2.3 Takeda Pharmaceutical Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Pharmaceutical Antacid Product Portfolio
  12. 8.2.5 Takeda Pharmaceutical Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Antacid Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Reckitt Benckiser
  20. 8.4.1 Reckitt Benckiser Company Information
  21. 8.4.2 Reckitt Benckiser Business Overview
  22. 8.4.3 Reckitt Benckiser Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Reckitt Benckiser Antacid Product Portfolio
  24. 8.4.5 Reckitt Benckiser Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Antacid Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 Procter＆Gamble
  32. 8.6.1 Procter＆Gamble Company Information
  33. 8.6.2 Procter＆Gamble Business Overview
  34. 8.6.3 Procter＆Gamble Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Procter＆Gamble Antacid Product Portfolio
  36. 8.6.5 Procter＆Gamble Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Antacid Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Johnson＆Johnson
  44. 8.8.1 Johnson＆Johnson Company Information
  45. 8.8.2 Johnson＆Johnson Business Overview
  46. 8.8.3 Johnson＆Johnson Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Johnson＆Johnson Antacid Product Portfolio
  48. 8.8.5 Johnson＆Johnson Recent Developments
  49. 8.9 CONBA
  50. 8.9.1 CONBA Company Information
  51. 8.9.2 CONBA Business Overview
  52. 8.9.3 CONBA Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CONBA Antacid Product Portfolio
  54. 8.9.5 CONBA Recent Developments
  55. 8.10 Xiuzheng Pharma
  56. 8.10.1 Xiuzheng Pharma Company Information
  57. 8.10.2 Xiuzheng Pharma Business Overview
  58. 8.10.3 Xiuzheng Pharma Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Xiuzheng Pharma Antacid Product Portfolio
  60. 8.10.5 Xiuzheng Pharma Recent Developments
  61. 8.11 Sanofi
  62. 8.11.1 Sanofi Company Information
  63. 8.11.2 Sanofi Business Overview
  64. 8.11.3 Sanofi Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Antacid Product Portfolio
  66. 8.11.5 Sanofi Recent Developments
  67. 8.12 Bausch Health
  68. 8.12.1 Bausch Health Company Information
  69. 8.12.2 Bausch Health Business Overview
  70. 8.12.3 Bausch Health Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bausch Health Antacid Product Portfolio
  72. 8.12.5 Bausch Health Recent Developments
  73. 8.13 CR SANJIU
  74. 8.13.1 CR SANJIU Company Information
  75. 8.13.2 CR SANJIU Business Overview
  76. 8.13.3 CR SANJIU Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CR SANJIU Antacid Product Portfolio
  78. 8.13.5 CR SANJIU Recent Developments
  79. 8.14 Reddy's Laboratories
  80. 8.14.1 Reddy's Laboratories Company Information
  81. 8.14.2 Reddy's Laboratories Business Overview
  82. 8.14.3 Reddy's Laboratories Antacid Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Reddy's Laboratories Antacid Product Portfolio
  84. 8.14.5 Reddy's Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antacid Value Chain Analysis
  2. 9.1.1 Antacid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antacid Production Mode & Process
  6. 9.2 Antacid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antacid Distributors
  9. 9.2.3 Antacid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst